The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro

NeuroToxicology

Volumn 33, Issue 3, 2012, Pages 416-423

  Hadrup, Niels ^a   Loeschner, Katrin ^a   Mortensen, Alicja ^a   Sharma, Anoop K ^a   Qvortrup, Klaus ^b   Larsen, Erik H ^a   Lam, Henrik R ^a,c  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DHI   (Denmark)

Author keywords

5 Hydroxytryptamine; Dopamine; Nanoparticle; Neurotoxicology; Noradrenaline; Silver

Indexed keywords

ACETATE SILVER; DEATH RECEPTOR; DOPAMINE; NORADRENALIN; SEROTONIN; SILVER; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL FRACTIONATION; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; NERVE CELL MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ACETATES; ANIMALS; APOPTOSIS; BRAIN; CELL SURVIVAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; METAL NANOPARTICLES; MITOCHONDRIA; NEURONS; NOREPINEPHRINE; PARTICLE SIZE; PC12 CELLS; RATS; RATS, WISTAR; RECEPTORS, DEATH DOMAIN; SEROTONIN; SILVER COMPOUNDS; TIME FACTORS; UP-REGULATION;

RATTUS;

EID: 84861185887     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.04.008     Document Type: Article

References (44)

1. AshaRani P.V., Low Kah M.G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
2. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology 1984, 5:13-35.
3. Bondy S.C., Anderson C.L., Harrington M.E., Prasad K.N. The effects of organic and inorganic lead and mercury on neurotransmitter high-affinity transport and release mechanisms. Environ Res 1979, 19:102-111.
4. Bonilla E. l-Tyrosine hydroxylase activity in the rat brain after chronic oral administration of manganese chloride. Neurobehav Toxicol 1980, 2:37-41.
5. Bouwmeester H., Poortman J., Peters R.J., Wijma E., Kramer E., Makama S., et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. ACS Nano 2011, 5:4091-4103.
6. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005, 88:412-419.
7. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008, 112:13608-13619.
8. Carpenter D.O. Effects of metals on the nervous system of humans and animals. Int J Occup Med Environ Health 2001, 14:209-218.
9. Chandra S.V., Shukla G.S., Saxena D.K. Manganese-induced behavioral dysfunction and its neurochemical mechanism in growing mice. J Neurochem 1979, 33:1217-1221.
10. Clarkson T.W. Metal toxicity in the central nervous system. Environ Health Perspect 1987, 75:59-64.
11. Donaldson J. Involvement of manganese in physiological and biochemical processes: an overview. Neurotoxicology 1984, 5:1-3.
12. Ehringer H., Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 2012, 38:1236-1239.
13. Eom H.J., Choi J. p38 MAPK activation. DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol 2010, 44:8337-8342.
14. Foldbjerg R., Olesen P., Hougaard M., Dang D.A., Hoffmann H.J., Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009, 190:156-162.
15. Hackenberg S., Scherzed A., Kessler M., Hummel S., Technau A., Froelich K., et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 2011, 201:27-33.
16. Hadrup N., Loeschner K., Bergstrom A., Wilcks A., Gao X., Vogel U., et al. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch Toxicol 2011.
17. Hadrup N., Petersen J.S., Windfeld S., Risom L., Andersen C.B., Nielsen S., et al. Differential down-regulation of aquaporin-2 in rat kidney zones by peripheral nociceptin/orphanin FQ receptor agonism and vasopressin type-2 receptor antagonism. J Pharmacol Exp Ther 2007, 323:516-524.
18. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 2006, 30:203-214.
19. Hsin Y.H., Chen C.F., Huang S., Shih T.S., Lai P.S., Chueh P.J. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008, 179:130-139.
20. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006, 92:456-463.
21. Lam H.R., Lof A., Ladefoged O. Brain concentrations of white spirit components and neurotransmitters following a three week inhalation exposure of rats. Pharmacol Toxicol 1992, 70:394-396.
22. Lee Y.S., Kim D.W., Lee Y.H., Oh J.H., Yoon S., Choi M.S., et al. Silver nanoparticles induce apoptosis and G2/M arrest via PKCzeta-dependent signaling in A549 lung cells. Arch Toxicol 2011.
23. Li P.W., Kuo T.H., Chang J.H., Yeh J.M., Chan W.H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett 2010, 197:82-87.
24. Loeschner K., Hadrup N., Qvortrup K., Larsen A., Gao X., Vogel U., et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011, 8:18.
25. Mattson M.P., Pedersen W.A., Duan W., Culmsee C., Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann N Y Acad Sci 1999, 893:154-175.
26. Miura N., Shinohara Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun 2009, 390:733-737.
27. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
28. Piao M.J., Kang K.A., Lee I.K., Kim H.S., Kim S., Choi J.Y., et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011, 201:92-100.
29. Powers C.M., Badireddy A.R., Ryde I.T., Seidler F.J., Slotkin T.A. Silver nanoparticles compromise neurodevelopment in PC12 cells: critical contributions of silver ion, particle size, coating, and composition. Environ Health Perspect 2011, 119:37-44.
30. Powers C.M., Levin E.D., Seidler F.J., Slotkin T.A. Silver exposure in developing zebrafish produces persistent synaptic and behavioral changes. Neurotoxicol Teratol 2011, 33:329-332.
31. Powers C.M., Wrench N., Ryde I.T., Smith A.M., Seidler F.J., Slotkin T.A. Silver impairs neurodevelopment: studies in PC12 cells. Environ Health Perspect 2010, 118:73-79.
32. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 2009, 187:15-21.
33. Rungby J., Danscher G. Hypoactivity in silver exposed mice. Acta Pharmacol Toxicol (Copenh) 1984, 55:398-401.
34. Savitt J.M., Dawson V.L., Dawson T.M. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 2006, 116:1744-1754.
35. Sharma H.S., Hussain S., Schlager J., Ali S.F., Sharma A. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir Suppl 2010, 106:359-364.
36. Takahashi Y., Mizuo K., Shinkai Y., Oshio S., Takeda K. Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. J Toxicol Sci 2010, 35:749-756.
37. Tang J., Xiong L., Wang S., Wang J., Liu L., Li J., et al. Influence of silver nanoparticles on neurons and blood-brain barrier via subcutaneous injection in rats. Appl Surf Sci 2008, 255:502-504.
38. Tang J., Xiong L., Zhou G., Wang S., Wang J., Liu L., et al. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J. Nanosci. Nanotechnol. 2010, 10:6313-6317.
39. Trickler W.J., Lantz S.M., Murdock R.C., Schrand A.M., Robinson B.L., Newport G.D., et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 2010, 118:160-170.
40. Wang J., Rahman M.F., Duhart H.M., Newport G.D., Patterson T.A., Murdock R.C., et al. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30:926-933.
41. Webster R.A. Neurotransmitters, drugs, and brain function 2011, John Wiley & Sons, Ltd.
42. Wei L., Tang J., Zhang Z., Chen Y., Zhou G., Xi T. Investigation of the cytotoxicity mechanism of silver nanoparticles in vitro. Biomed Mater 2010, 5:1-6.
43. Woodrow Wilson International Center for Scholars Project on emerging nanotechnologies 2011, http://www.nanotechprojects.org/inventories/consumer.
44. Zhang Z., Zhao B., Hu L. PVP Protective Mechanism of Ultrafine Silver Powder Synthesized by Chemical Reduction Processes. J Solid State Chem 1996, 121:105-110.